Transmeta and NVIDIA Announce Strategic Collaboration

Companies Team to Deliver Leading Multimedia and Graphics Capabilities for the Transmeta Efficeon Processor


Kenn Durrence      
Transmeta Corporation    

Diane Vanasse
NVIDIA Corporation

Santa Clara, Calif.; September 17, 2003…Transmeta Corporation (Nasdaq: TMTA), the leader in efficient computing, and NVIDIA Corporation (Nasdaq: NVDA), the worldwide leader in visual processing solutions, today announced a collaboration where NVIDIA has agreed to develop its highly integrated media communications processors for Transmeta’s next generation Efficeon™ processor, enabling exceptional multimedia and graphics capabilities for a wide range of mobile PC platforms.

“Future PC platforms will be integrated multimedia powerhouses that run efficiently and quietly and deliver amazing multimedia capabilities in a small package,” said Dr. Jon Peddie, multimedia and graphics industry expert and president, Jon Peddie Research. “The combination of Transmeta’s prowess in efficient processing combined with NVIDIA’s expertise in multimedia and graphics creates a world-class partnership that will benefit a multitude of PC platforms. Our research shows this category to be the fastest growing and largest segment in the PC market, and we expect a whole new class of products to emerge.”

Transmeta and NVIDIA have collaborated to leverage their respective expertise in energy efficient processor design, dynamic power management and graphics. The companies have teamed to deliver an exceptional combination of features, battery life, and a compact platform size for emerging classes of small form factor computers.

"Transmeta’s collaboration with NVIDIA, an industry leader, will spur innovative graphics capabilities in mobile devices,” said Dr. Matthew R. Perry, president and CEO, Transmeta Corporation. “Transmeta’s customers are delivering exceptional efficient computing form factors featuring extended battery life, low heat, award winning designs, integrated functionality and highly competitive pricing.”

“NVIDIA's collaboration with Transmeta enables a new class of ultra portable mobile computer,” said Jen-Hsun Huang, CEO and President, NVIDIA Corporation. “As the mobile computer increasingly becomes the primary computing device for many people, the demand for smaller form factor, low power solutions becomes apparent. By closely collaborating with Transmeta, our combined technologies are enabling computer makers to deliver an outstanding multimedia experience in stunningly small, low power devices.”

Transmeta’s new Efficeon processor, in production during the current quarter, provides industry leadership in delivering power efficiency and high performance for notebooks, tablet PCs, ultra-personal computers, silent desktops, blade servers and embedded systems.

Dave Ditzel, Transmeta’s co-founder and chief technology officer, will make a presentation about the new Efficeon processor, including detailed specifications and benchmark data, at Microprocessor Forum in San Jose, October 13-16, 2003.

About Transmeta Corporation
Transmeta Corporation develops and sells software-based microprocessors and develops additional hardware, software and system technologies that enable manufacturers to build highly efficient computing systems characterized by low power consumption, reduced heat dissipation and the high performance required to run standard x86 compatible programs. We originally developed our family of Crusoe microprocessors for lightweight notebook computers and other mobile computing devices, but we have developed and are continuing to develop microprocessors suitable for a variety of existing and emerging end markets in which x86 program compatibility and energy and thermal efficiency are desirable. To learn more about Transmeta, visit www.transmeta.com.

About NVIDIA Corporation
NVIDIA Corporation is a market leader in visual computing technology dedicated to creating products that enhance the interactive experience on consumer and professional computing platforms. Its graphics and communications processors have broad market reach and are incorporated into a wide variety of computing platforms, including consumer digital-media PCs, enterprise PCs, professional workstations, digital content creation systems, notebook PCs, military navigation systems and video game consoles. NVIDIA is headquartered in Santa Clara, California and employs more than 1,600 people worldwide.  For more information, visit the Company’s Web site at www.nvidia.com.

Transmeta, Efficeon and Crusoe are trademarks of Transmeta Corporation. All other product or service names mentioned herein are the trademarks of their respective owners.

Transmeta Safe Harbor Statement
This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements speak only as of the date of this release, and we will not necessarily provide updates of our projections or other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to many risks and uncertainties, and may differ materially or adversely from our actual results or future events. Important risk factors that could have material or adverse effects on our results include general economic and political conditions and specific conditions and volatility in the markets that we address, the rescheduling or cancellation of significant customer orders, market acceptance and adoption of our new products by our present and future customers and end users, difficulties in developing or manufacturing new and existing products in a timely and cost effective manner, our dependence on third parties for sourcing materials and providing manufacturing services, intense competition and competitive pressures, patents and other intellectual property rights, and other risk factors. We urge investors to review our filings with the Securities and Exchange Commission, including our most recent reports on Forms 10-K and 10-Q, which describe these and other important risk factors that could have an adverse effect on our results. We undertake no obligation to revise or update publicly any forward-looking statement for any reason.